Pages that link to "Q48743536"
Jump to navigation
Jump to search
The following pages link to Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma (Q48743536):
Displaying 24 items.
- Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children (Q24235303) (← links)
- Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma (Q24235964) (← links)
- Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children (Q24240464) (← links)
- Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma (Q24245383) (← links)
- Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma (Q24245643) (← links)
- Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults (Q24245719) (← links)
- Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children (Q24245892) (← links)
- Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review (Q24794527) (← links)
- Interactions between corticosteroids and beta agonists (Q33944522) (← links)
- Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma (Q34112937) (← links)
- Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists? (Q34212920) (← links)
- Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management (Q34523871) (← links)
- Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma (Q35040750) (← links)
- Long-acting beta2-agonists: comparative pharmacology and clinical outcomes (Q35627925) (← links)
- Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. (Q36246222) (← links)
- Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma (Q36761823) (← links)
- A cost-effectiveness analysis of first-line controller therapies for persistent asthma (Q36870013) (← links)
- Inhaled corticosteroid dosing: Double for nothing? (Q37881498) (← links)
- Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation. (Q38043452) (← links)
- Using case management to increase antiinflammatory medication use among a managed care population with asthma (Q39409694) (← links)
- Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy (Q43510996) (← links)
- Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy (Q43631501) (← links)
- Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis (Q44131798) (← links)
- Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5. (Q45053714) (← links)